Literature DB >> 9787010

Functional consequences of central serotonin depletion produced by repeated fenfluramine administration in rats.

M H Baumann1, M A Ayestas, R B Rothman.   

Abstract

Repeated administration of D,L-fenfluramine (FEN) is known to cause prolonged depletion of forebrain serotonin (5-HT) in animals. Ironically, few studies have evaluated functional consequences of such FEN-induced 5-HT loss. In the present work, we examined neuroendocrine and behavioral responses evoked by acute FEN injection in rats that had previously received a 4 d FEN-dosing regimen known to deplete forebrain 5-HT (D,L-FEN, 20 mg/kg, s.c., b. i.d.). Rats were fitted with indwelling jugular catheters before the study to allow for repeated intravenous challenge injections and stress-free blood sampling. At 1 and 2 weeks after the 4 d dosing regimen, acute FEN (1.5 or 3.0 mg/kg, i.v.) produced dose-related elevations in plasma corticosterone and prolactin; these hormonal responses were markedly attenuated in FEN-pretreated rats. Behavioral effects of acute FEN, namely flat body posture and forepaw treading, were also blunted in FEN-pretreated rats. Interestingly, rats exposed to repeated FEN did not display overt abnormalities in hormonal or behavioral parameters under basal (i.e., unprovoked) conditions, despite dramatic decreases in postmortem tissue levels of 5-HT in numerous brain areas. Our results suggest that FEN-induced 5-HT depletion is accompanied by multiple impairments in 5-HT function. Although the clinical relevance of our data are debatable, the findings clearly show the utility of the FEN challenge test for uncovering in vivo functional deficits that might otherwise go undetected. FEN should remain an important pharmacological tool for determining the role of 5-HT neurons in mediating diverse physiological and behavioral processes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9787010      PMCID: PMC6793553     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  48 in total

Review 1.  Neuroendocrine pharmacology of serotonergic (5-HT) neurons.

Authors:  L D Van de Kar
Journal:  Annu Rev Pharmacol Toxicol       Date:  1991       Impact factor: 13.820

2.  Role for brain corticotropin-releasing factor in the weight-reducing effects of chronic fenfluramine treatment in rats.

Authors:  N M Appel; M J Owens; S Culp; R Zaczek; J F Contrera; G Bissette; C B Nemeroff; E B De Souza
Journal:  Endocrinology       Date:  1991-06       Impact factor: 4.736

3.  Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: evidence from immunocytochemical studies.

Authors:  N M Appel; J F Contrera; E B De Souza
Journal:  J Pharmacol Exp Ther       Date:  1989-06       Impact factor: 4.030

4.  Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms.

Authors:  E Sanders-Bush; J A Bushing; F Sulser
Journal:  J Pharmacol Exp Ther       Date:  1975-01       Impact factor: 4.030

5.  Effects of high-dose fenfluramine treatment on monoamine uptake sites in rat brain: assessment using quantitative autoradiography.

Authors:  N M Appel; W M Mitchell; J F Contrera; E B De Souza
Journal:  Synapse       Date:  1990       Impact factor: 2.562

6.  Anatomic evidence for a neurotoxic effect of (+/-)-fenfluramine upon serotonergic projections in the rat.

Authors:  D C Molliver; M E Molliver
Journal:  Brain Res       Date:  1990-03-12       Impact factor: 3.252

Review 7.  Appetite suppressants. A review.

Authors:  T Silverstone
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

8.  Serotonergic mediation of the suckling-induced release of prolactin in the lactating rat.

Authors:  D Rowland; M Steele; H Moltz
Journal:  Neuroendocrinology       Date:  1978       Impact factor: 4.914

9.  The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

Authors:  M D Tricklebank; C Forler; J R Fozard
Journal:  Eur J Pharmacol       Date:  1984-11-13       Impact factor: 4.432

10.  d-Fenfluramine and d-norfenfluramine hypophagias do not require increased hypothalamic 5-hydroxytryptamine release.

Authors:  A O Oluyomi; E L Gibson; A M Barnfield; G Curzon
Journal:  Eur J Pharmacol       Date:  1994-10-13       Impact factor: 4.432

View more
  8 in total

1.  Rats preexposed to MDMA display attenuated responses to its aversive effects in the absence of persistent monoamine depletions.

Authors:  Daniel L Albaugh; Jennifer A Rinker; Michael H Baumann; Jacquelyn R Sink; Anthony L Riley
Journal:  Psychopharmacology (Berl)       Date:  2011-03-05       Impact factor: 4.530

2.  Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3.

Authors:  Loreto A Egaña; Rolando A Cuevas; Tracy B Baust; Leonardo A Parra; Rehana K Leak; Sarah Hochendoner; Karina Peña; Marisol Quiroz; Weimin C Hong; Mario M Dorostkar; Roger Janz; Harald H Sitte; Gonzalo E Torres
Journal:  J Neurosci       Date:  2009-04-08       Impact factor: 6.167

Review 3.  3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.

Authors:  Michael H Baumann; Xiaoying Wang; Richard B Rothman
Journal:  Psychopharmacology (Berl)       Date:  2006-03-16       Impact factor: 4.530

Review 4.  Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.

Authors:  Gary A Gudelsky; Bryan K Yamamoto
Journal:  Pharmacol Biochem Behav       Date:  2007-10-16       Impact factor: 3.533

5.  Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain.

Authors:  Michael H Baumann; Robert D Clark; Richard B Rothman
Journal:  Pharmacol Biochem Behav       Date:  2008-03-04       Impact factor: 3.533

6.  Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA).

Authors:  Michael H Baumann; Richard B Rothman
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

7.  Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges.

Authors:  M H Baumann; R D Clark; F H Franken; J J Rutter; R B Rothman
Journal:  Neuroscience       Date:  2008-01-12       Impact factor: 3.590

8.  Early life environmental and pharmacological stressors result in persistent dysregulations of the serotonergic system.

Authors:  Peiyan Wong; Ying Sze; Laura Jane Gray; Cecilia Chin Roei Chang; Shiwei Cai; Xiaodong Zhang
Journal:  Front Behav Neurosci       Date:  2015-04-27       Impact factor: 3.558

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.